IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $105,000 | -3.7% | 6,850 | 0.0% | 0.02% | -4.5% |
| Q3 2016 | $109,000 | +91.2% | 6,850 | +24.5% | 0.02% | +46.7% |
| Q3 2015 | $57,000 | -13.6% | 5,500 | 0.0% | 0.02% | -11.8% |
| Q2 2015 | $66,000 | -25.0% | 5,500 | 0.0% | 0.02% | -22.7% |
| Q1 2015 | $88,000 | +4.8% | 5,500 | 0.0% | 0.02% | -4.3% |
| Q4 2014 | $84,000 | +18.3% | 5,500 | 0.0% | 0.02% | +4.5% |
| Q3 2014 | $71,000 | +2.9% | 5,500 | +22.2% | 0.02% | 0.0% |
| Q2 2014 | $69,000 | +25.5% | 4,500 | 0.0% | 0.02% | +22.2% |
| Q1 2014 | $55,000 | +5.8% | 4,500 | 0.0% | 0.02% | -5.3% |
| Q4 2013 | $52,000 | -41.6% | 4,500 | -40.0% | 0.02% | -47.2% |
| Q3 2013 | $89,000 | +20.3% | 7,500 | 0.0% | 0.04% | +2.9% |
| Q2 2013 | $74,000 | -32.7% | 7,500 | +25.0% | 0.04% | -37.5% |
| Q1 2013 | $110,000 | +66.7% | 6,000 | 0.0% | 0.06% | +30.2% |
| Q4 2012 | $66,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |